Goldspire™: Developing a Fast Turnaround Individualized Cancer Vaccinelike Immunotherapy to Reduce Manufacturing Time & Treat Patients Faster
Time: 4:00 pm
day: Pre-Conference Focus Day
Details:
- Creating an individualized treatment by whole tumor to overcome heterogeneity with the most comprehensive antigens
- Reducing the personalized cancer vaccine timeline by central manufacturing and optimized logistics
- Ensuring cGMP cancer vaccine process consistency and quality by using a central manufacture site for alignment with the FDA
